Actavis Asks Full Fed. Circ. To Nix ‘Amorphous’ Panel Ruling

Actavis Laboratories FL Inc. asked the full Federal Circuit on Wednesday to revisit an August panel decision in a case over weight loss pill patents, citing a partial dissent by one of the panel judges who had argued the decision wrongly created a “new rule” for written description…

Read this piece in its entirety at Law360.


Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s